How IL-6 allows the immune response to develop for a key cell, the T follicular helper

A preclinical study shows how the interplay of two interleukin signaling proteins, IL-6 and IL-2, affects the development of T follicular helper cells and germinal centers. This interplay may either maintain or disrupt the balancing act of the immune system between attacking infections and benign surveillance of the body's own cells. Thus, the research may help guide future disease treatment for autoimmune diseases like lupus.

Read more

Tiny bubbles in our body could fight cancer better than chemo

Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly. These bubbly extracellular vesicles could become mini treatment transporters, carrying a combination of therapeutic drugs and genes that target cancer cells and kill them, according to new research from Michigan State University and Stanford University.

Read more